Hanna Iderberg

"Hanna Iderberg"
Mean distance: 17.2 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Iderberg H, Maslava N, Thompson AD, et al. (2015) Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology. 95: 121-9
Iderberg H, McCreary AC, Varney MA, et al. (2015) Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia Neuropharmacology. 93: 52-67
Iderberg H, McCreary AC, Varney MA, et al. (2015) NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat Experimental Neurology. 271: 335-350
Francardo V, Iderberg H, Lindgren H, et al. (2014) Rodent Models of Treatment-Related Complications in Parkinson Disease Movement Disorders: Genetics and Models: Second Edition. 373-386
Iderberg H, Rylander D, Bimpisidis Z, et al. (2013) Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action. Experimental Neurology. 250: 116-24
Iderberg H, Francardo V, Pioli EY. (2012) Animal models of l-DOPA-induced dyskinesia: An update on the current options Neuroscience. 211: 13-27
Lindgren HS, Rylander D, Iderberg H, et al. (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. Journal of Parkinson's Disease. 1: 347-57
Rylander D, Iderberg H, Li Q, et al. (2010) A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiology of Disease. 39: 352-61
See more...